SS
TMO icon

Spinecap SAS’s Thermo Fisher Scientific TMO Stock Holding History

Spinecap SAS’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3M Buy
72,481
+2,973
+4% +$1.43M 10.86% 4
2026
Q1 		$34.2M Sell
69,508
-520
-0.7% -$282K 12.54% 3
2025
Q4 		$40.6M Sell
70,028
-3,416
-5% -$1.93M 17.44% 2
2025
Q3 		$35.6M Hold
73,444
– – 15.68% 2
2025
Q2 		$29.8M Buy
+73,444
New +$30.7M 15.5% 2

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Spinecap SAS's TMO Position: Q2 2026 in Review

Spinecap SAS increased its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, buying an estimated $1.43M and bringing the position to 72,481 shares worth $36.3M. The position accounts for 10.86% of the portfolio, ranked #4.

Spinecap SAS first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $40.6M in Q4 2025. 1,015 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Spinecap SAS held 72,481 shares of Thermo Fisher Scientific worth $36.3M as of Q2 2026.
  • Spinecap SAS bought 2,973 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.43M.
  • Thermo Fisher Scientific made up 10.86% of Spinecap SAS's portfolio in Q2 2026, its #4 holding.
  • Spinecap SAS first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Spinecap SAS's Thermo Fisher Scientific position peaked at $40.6M in Q4 2025.
  • 1,015 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Spinecap SAS's 13F filing for Q2 2026, filed 27 Jul 2026.